Guangdong Hybribio Biotech (300639.SZ) plans to spend 50 million to 100 million yuan to repurchase shares, with the repurchase price not exceeding 9 yuan per share.
Capstone Biology (300639.SZ) announced that the company plans to use its own funds and bank special repurchase loan funds in order to concentrate...
Guangdong Hybribio Biotech (300639.SZ) announced that the company plans to use own funds and bank special repurchase loan funds to repurchase some of its shares through centralized competitive trading. The total amount of funds will not be less than RMB 50 million (inclusive) and not exceed RMB 100 million (inclusive). The repurchase price of the shares shall not exceed RMB 9.00 per share (inclusive). The implementation period of the share repurchase shall not exceed 3 months from the date of approval by the board of directors.
Related Articles
PW MEDTECH (01358) spent HKD 640,900 to repurchase 436,000 shares on October 24th.
Appointment of Mr. Wen Xiaojian as Executive Director and Acting Chief Executive Officer of ZHAOBANGJI LIFE (01660)
On October 24th, MENGNIU DAIRY (02319) spent 5.7447 million Hong Kong dollars to repurchase 400,000 shares.
PW MEDTECH (01358) spent HKD 640,900 to repurchase 436,000 shares on October 24th.
Appointment of Mr. Wen Xiaojian as Executive Director and Acting Chief Executive Officer of ZHAOBANGJI LIFE (01660)
On October 24th, MENGNIU DAIRY (02319) spent 5.7447 million Hong Kong dollars to repurchase 400,000 shares.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
